Abstract
BackgroundDespite the large number of studies on safety of anti-SARS-CoV-2 vaccines in people with rheumatic and musculoskeletal diseases (RMDs), data on Sjögren’s syndrome (SS) are scarce.ObjectivesTo determine anti-SARS-CoV-2 vaccine-related adverse...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
